Dr. Nikolsky has 20 years of experience in life sciences, both business and research. Currently, he is VP R&D at Thomson Reuters (TR), a leading provider of intelligent information. Prior, Dr. Nikolsky was CEO of GeneGo, a systems biology company acquired by TR in 2010. Prior to GeneGo, he was CEO of ChemDiv (San Diego, CA), a drug discovery CRO. Dr. Nikolsky also co-founded Integrated Genomics, Inc. (Chicago, IL), a comparative genomics and bioinformatics company and held positions of senior scientist for Thermogen, Inc. (Chicago, IL) and instructor at the University of Chicago. Dr. Nikolsky holds an MBA degree in finance from the Booth School of Business (University of Chicago) and a doctoral degree in molecular genetics from VNII Genetika Graduate School in Moscow, Russia. Dr. Nikolsky’s current research interests are in disease research, personalized and translational medicine. Dr. Nikolsky has authored over 70 research articles and 4 patents.